Lion invests in $100M US oral-health fund from Revere Partners
What's the deal? Lion CorporationDealroom has a profile for this one. Try Dealroom → has signed an agreement to invest in Revere Partners Fund III, a $100 million venture fund run by New York-based Revere Partners RF, LLCDealroom has a profile for this one. Try Dealroom →. The fund backs private oral-health-focused healthcare technology companies in the US.
More on the fund: Established in 2025, Fund III has a 10-year term, with a possible extension of up to two years. It targets attractive long-term returns through a general venture capital strategy.
Who's Revere? Founded in 2021 by dentist and MBA holder Jeremy KrellDealroom has a profile for this one. Try Dealroom →, Revere is an independent VC specialising in the dental and oral-health space. Krell built the firm on his clinical experience and work supporting oral-health startups.
The firm's edge is its network across US dental associations, clinics, insurers, materials and equipment makers, and dealers, which it uses to source and support startups. It also offers corporate investors end-to-end support, from finding promising companies to backing collaboration.
Why now? The investment supports LionDealroom has a profile for this one. Try Dealroom →'s mid-term plan, "Vision2030 2nd STAGE," which prioritises strengthening earnings power through portfolio management. Oral healthcare (OHC) is the company's top-priority business.
Through the investment, Lion aims to accelerate co-creation with startups and apply what it learns across Asia, its main market, to create new business opportunities.
What's the endgame? Lion wants to expand OHC beyond oral hygiene into oral function — the ability to chew, swallow, and enjoy conversation. It sees the US as a leading market for OHC business development.
The signal: The deal shows a consumer-goods company using a specialist US fund as a window into a narrow but growing healthcare niche — and a way to import Western innovation into Asian markets.
Image credit: smilesmangohill
Read more: PR Times
